Corteva, Inc. (NYSE:CTVA) Receives $82.80 Consensus Target Price from Analysts

Shares of Corteva, Inc. (NYSE:CTVA) have earned an average recommendation of “Moderate Buy” from the twenty-two ratings firms that are covering the company, MarketBeat reports. Eight analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $82.80.

CTVA has been the subject of several research analyst reports. JPMorgan Chase & Co. lowered Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the stock from $75.00 to $77.00 in a research note on Thursday, February 5th. Citigroup boosted their target price on Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. CICC Research raised their price target on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. Wells Fargo & Company lifted their price target on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Argus upgraded shares of Corteva to a “strong-buy” rating in a research note on Friday, January 16th.

Corteva Stock Performance

Shares of CTVA stock opened at $76.57 on Tuesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The firm has a market capitalization of $51.49 billion, a price-to-earnings ratio of 48.46, a price-to-earnings-growth ratio of 2.67 and a beta of 0.72. Corteva has a one year low of $53.40 and a one year high of $80.90. The company has a 50 day moving average price of $72.81 and a 200 day moving average price of $69.02.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts anticipate that Corteva will post 2.96 EPS for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.14% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Corteva

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Chilton Capital Management LLC grew its position in Corteva by 18.1% during the third quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after purchasing an additional 68,380 shares in the last quarter. TriaGen Wealth Management LLC acquired a new stake in shares of Corteva during the 3rd quarter valued at $4,284,000. Truist Financial Corp boosted its stake in shares of Corteva by 4.5% during the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock valued at $21,771,000 after buying an additional 13,910 shares during the period. New York State Teachers Retirement System grew its holdings in shares of Corteva by 4.5% during the 3rd quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock valued at $37,290,000 after acquiring an additional 23,548 shares in the last quarter. Finally, Alberta Investment Management Corp acquired a new position in shares of Corteva in the third quarter worth $5,018,000. 81.54% of the stock is owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.